Author: Rajeev Singla

GlaxoSmithKline (GSK), one of the world’s leading research-based pharmaceutical and healthcare companies, and Prosensa, a Dutch biotechnology company, have reported that GSK’s phase III clinical study of drisapersen, an investigational anti-sense oligonucleotide, for the treatment of Duchenne Muscular Dystrophy (DMD) patients with an amenable mutation, did not meet the primary endpoint of a statistically significant improvement in the 6 Minute Walking Distance (6MWD) test compared to placebo. To read full news, visit: http://pharmabiz.com/NewsDetails.aspx?aid=77785&sid=2 References: http://pharmabiz.com/

Read More

New experiments conducted by researchers from the University of Copenhagen (Denmark) show that the amino acid arginine – found in a wide variety of foods such as salmon, eggs and nuts – greatly improves the body’s ability to metabolise glucose. Arginine stimulates a hormone linked to the treatment of type 2 diabetes, and works just as well as several established drugs on the market. The research findings have just been published in the scientific journal Endocrinology. To read full article, visit: http://www.worldpharmanews.com/research/2541-amino-acid-with-promising-anti-diabetic-effects Reference: http://www.worldpharmanews.com/

Read More

Novartis and Malaria No More announced today the debut of the Power of One campaign, encouraging people around the world to help end child deaths from malaria. Novartis will support the campaign financially and donate up to three million Coartem® Dispersible treatments to match antimalarials funded by the public. The company’s commitment to Power of One aligns with its long history in the fight against malaria; the Novartis Malaria Initiative is one of the largest access-to-medicine programs in the healthcare industry. Malaria is a preventable and treatable disease, but it still kills a child every minute. It is estimated that…

Read More

Mr. Salam Pradeep Singh, Dept. of Molecular Biology and Biotechnology, Tezpur University, Tezpur-784028, Assam, India is handling a special issue “Computational Drug Design & Pharmaceutical Research” Aims and Scope of the Special Issue – Molecular docking studies – Molecular modeling – Insilico ADME-Toxicity – Homology modeling – QSAR studies – Molecular dynamics – Bind free energy calculations – Molecular descriptors analysis and – Theoretical chemistry Submission Format and Guideline All submitted papers must be in good, clearly written English and contain only original work, which has not been published by or is currently under review for any other journal or…

Read More

We are pleased to announce that Indo Global J Pharm Sciences is now indexed & abstracted in 34 more spaces Including WHO – Hinari. List is given as below. Details will soon be uploaded on the website. Latest Indexing of Indo Global Journal of Pharmaceutical Sciences 1. Forest Product Abstracts-CABI 2. Helminthological Abstracts-CABI 3. Review of Plant Pathology-CABI 4. Forestry Abstracts-CABI 5. Botanical Pesticides- CABI 6. Review of Medical & Veterinary Mycology- CABI 7. Post Harvest News & Information- CABI 8. Horticultural Science Abstracts-CABI 9. Global Health-CABI 10. Environmental Science Database- CABI 11. Review of Aromatic & Medicinal Plants- CABI…

Read More

Dear Valued Researcher, Greetings from Indo Global Journal of Pharmaceutical Sciences (ISSN 2249 1023 ; CODEN IGJPAI) http://iglobaljournal.com We would like to take this opportunity to inform you that we have found some very good papers of your interest. These articles are worth for the readers and we appreciate if you may view articles of your interest and cite in your next Research/Review Articles. Indo Global Journal of Pharmaceutical Sciences is an international, peer reviewed, quarterly published journal with Indexing in Elsevier, Embase, EBSCO, SCIRUS, Chemical Abstract Services(CAS), American Chemical Scoeity(ACS), CASSI, Science Central, Academic Search, DOAJ, Google Scholar, Google,…

Read More

Dear Fellow Researchers, Greetings from Indo Global J Pharm Sciences. Every researcher aimed to the significant results, have a dream that his/her research project will be the best one and work really hard for it. But sometimes at the end of day, results were not coming upto his/her & scientific world expectations. His/her supervisor tried to point out mistakes in the project. Researcher have only two options at that time, either put the results in dump or do the malpractice i.e. manipulate results. I suggest none of these as both are fatal for science. If you do the manipulations,…

Read More

FRIDAY May 25, 2012 — People in lower Manhattan whose homes were damaged in the 9/11 terrorist attacks are more likely to have symptoms of respiratory diseases than those whose homes were not damaged, a new study indicates. Thousands of lower Manhattan residents experienced some type of damage to their homes — such as broken windows and ruined furnishings — after the collapse of the World Trade Center’s Twin Towers. Previous studies found an increased level of asthma among residents who had a heavy layer of dust in their homes after the attacks. The new findings examine how damage to…

Read More